• Polares Medical Closes a $25M Financing to Enter Clinical Validation b3cnewswire
    July 24, 2018
    Polares Medical SA, a preclinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR), announced today the closing of a $25
PharmaSources Customer Service